Review of incidence and outcomes of treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis.

World J Gastrointest Oncol · 2021 · PMC8529934 · PMID 34721770

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

PSC patients showed a trend towards higher but not statistically significant survival compared to the de novo PHCCA patients, both after the start of neoadjuvant therapy and after OLT.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.